Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
215,324,536
-
Share change
-
-3,107,274
-
Total reported value
-
$8,688,484,219
-
Put/Call ratio
-
53%
-
Price per share
-
$40.35
-
Number of holders
-
708
-
Value change
-
-$122,050,696
-
Number of buys
-
286
-
Number of sells
-
339
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q4 2015
As of 31 Dec 2015,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
708 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
215,324,536 shares.
The largest 10 holders included
FMR LLC, JPMORGAN CHASE & CO, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, ROYAL BANK OF CANADA, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, FEDERATED INVESTORS INC /PA/, and Bank of New York Mellon Corp.
This page lists
708
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.